Chemomab Therapeutics Ltd - ADR

NASDAQ:CMMB   3:59:52 PM EDT
12.04
-0.24 (-1.95%)
Earnings Announcements

Chemomab Therapeutics Announces Q2 Results

Published: 08/13/2021 12:35 GMT
Chemomab Therapeutics Ltd - ADR (CMMB) - Chemomab Therapeutics - Cash and Equivalents As of June 30 Expected to Fund Current Operating Plan Through Mid 2023.
Q2 Loss per Share $0.01.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.02

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.02

More details on our Analysts Page.